Bernd Panholzer, Tido Bajorat, Assad Haneya, Dorothee Kowalski, David Juhl, Angela Rocke, Maria Shneyder, Piotr Kuta, Hartmut Clausnizer, Ralf Junker, Arne Kowalski, Aysun Tulun, Akram Al-Suraimi, Jochen Cremer, Johannes Kalbhenn, Barbara Zieger, Ulrike Nowak-Göttl
BACKGROUND: Bleeding is a common but possibly underreported side effect of Extracorporeal Membrane Oxygenation (ECMO). Impairment of primary hemostasis by acquired von Willebrand syndrome (aVWS) and platelet dysfunction as well as activation and consumption of plasmatic coagulation factors contribute to hemorrhage. The aim of the present cohort study of consecutively enrolled patients admitted to our ECMO center was to collect demographic, medical and laboratory data possibly associated with i) development of clinically relevant bleeding and/or ii) death during a 12-months follow-up...
March 2021: Blood Cells, Molecules & Diseases